This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Index Pharmaceuticals Ab. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Asa Karlsson: Innovator in Cancer Treatment
Introduction
Asa Karlsson is a notable inventor based in Sollentuna, Sweden. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds. His work focuses on the use of specific oligonucleotide sequences to inhibit tumor growth, showcasing the potential for advancements in cancer therapies.
Latest Patents
Asa Karlsson holds a patent for "Tumour growth inhibitory compounds and methods of their use." This patent describes specific CpG oligonucleotide sequences that, when administered subcutaneously or through mucous membranes, have shown a profound effect on various human cancer forms. The efficacy of these compounds has been confirmed through in vivo studies in animals and in vitro studies using human peripheral blood mononuclear cells (PBMCs) from both healthy subjects and patients suffering from chronic lymphocytic leukemia (CLL) or follicular lymphoma (FL). The compounds are designed to be used in combination with various cancer therapies, including immunological treatments, which may involve the administration of antibodies.
Career Highlights
Asa Karlsson is associated with Index Pharmaceuticals AB, where he continues to advance his research in cancer therapies. His work is characterized by a commitment to improving treatment options for patients facing challenging diagnoses. With a focus on innovative solutions, he has positioned himself as a key figure in the pharmaceutical industry.
Collaborations
Asa collaborates with talented professionals in his field, including Oliver Von Stein and Arezou Zargari. Their combined expertise contributes to the development of groundbreaking therapies that aim to enhance patient outcomes in cancer treatment.
Conclusion
Asa Karlsson's contributions to cancer research and treatment exemplify the impact of innovative thinking in the medical field. His patent for tumor growth inhibitory compounds represents a significant step forward in the fight against cancer. Through his work at Index Pharmaceuticals AB, he continues to pave the way for future advancements in cancer therapies.